Position of the Transparency Council – Shingrix
At its meeting on 18 November 2024, the Transparency Council adopted position No. 124/2024 on the evaluation of Shingrix vaccine in the indication for the prevention of hemiplegia and hemiplegic neuralgia
Publication of the position >>